Company Filing History:
10 out of 17 
4 out of 111 
1 out of 207 Years Active: 1990-2002
Title: Thomas B Okarma: Innovator in Cell Capture Technology
Introduction
Thomas B Okarma is a prominent inventor based in Palo Alto, CA (US). He has made significant contributions to the field of cell capture and recovery, holding a total of 15 patents. His work focuses on developing devices and processes that enhance the separation of cells from various mixtures, which is crucial for research, diagnosis, and therapy.
Latest Patents
One of his latest patents is a device and process for cell capture and recovery. This innovation provides effective separation of cells from a mixture, utilizing depletion or positive selection to yield a cellular population of interest. It is particularly useful for isolating cells from peripheral blood mononuclear cells, allowing for the extraction of lymphoid or myeloid lineage cells. These isolated cells can be employed for various purposes, including research and therapeutic applications. The technology also facilitates the separation of cells from bone marrow, tumor suspensions, or lymphoid tissue suspensions. The resulting cells are homogeneous, viable, capable of replication, and exhibit their full biological activities. Additionally, multiple phenotypes can be captured simultaneously, and the cells can be specifically activated with cytokines and antigens to ensure MHC restriction and antigen-specific effector functions.
Career Highlights
Throughout his career, Thomas B Okarma has worked with notable companies such as Applied Immunesciences, Inc. and Rhone-Poulenc Rorer Pharmaceuticals Inc. His experience in these organizations has contributed to his expertise in the field of cell capture technology.
Collaborations
He has collaborated with esteemed colleagues, including Jane S Lebkowski and Maureen A McNally, further enhancing the impact of his work in the scientific community.
Conclusion
Thomas B Okarma's innovative contributions to cell capture technology have paved the way for advancements in research and therapeutic applications. His patents reflect a commitment to improving the efficiency and effectiveness of cell separation processes.